MedTrace Logo

Treatment of Post-Traumatic Brain Injury (TBI) Depression

NCT00233103 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2015-11-13

Study results available
· View outcomes & findings →

Summary

Randomized clinical trial of sertraline vs. placebo for post-TBI depression

Conditions

Interventions

DRUG

Sertraline

Sertraline arm

DRUG

Placebo

Placebo

Sponsors & Collaborators

Principal Investigators

  • Wayne Gordon, Ph.D. · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00233103 on ClinicalTrials.gov